Jim Kirchner, Ph.D. joined the team at Kezar in April 2024 as Vice President of CMC and Supply Chain. Prior to joining us he held leadership positions in organizations focused on CMC development. He has built technical operations teams from Phase 1 through commercial launch, encompassing analytical, process and formulation development as well as drug substance and drug product manufacturing. Additionally, Jim’s career has included developing duplex oligonucleotide therapeutics at Corgentech, Capsaicin at Anesiva, ergot alkaloids at MAP Pharmaceuticals, aminogycoside at Achaogen, and most recently proteins at Alladapt.

Jim received his B.S in Chemistry from Kent State University and his Ph.D. in chemistry from the University of Washington.